LinKinVax Introduces its Scientific Advisory Board with the Appointment of Three Leading Experts in Immunology and Epidemiology

PARIS--(BUSINESS WIRE)--LinKinVax, a clinical-stage biotechnology company, announces the creation of its Scientific Advisory Board with the appointment of three experts in immunology and epidemiology. “We are delighted to welcome Prof. Anna Giuliano, Prof. Sharon Lewin and Prof. Giuseppe Pantaleo to our Scientific Advisory Board. The world-class expertise of these scientists in infectious diseases, immune diseases and cancer will be crucial to LinKinVax, which is developing a DC-targeting vacci